Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients

Adan Z. Becerra,Christopher T. Aquina,Supriya G. Mohile,Mohamedtaki Abdulaziz Tejani,Maria J. Schymura,Francis P. Boscoe,Zhaomin Xu,Carla F. Justiniano,Courtney I. Boodry,Alex A. Swanger,Katia Noyes,John R. T. Monson,Fergal J. Fleming

Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients

2017

Adan Z. Becerra
Christopher T. Aquina
Supriya G. Mohile
Mohamedtaki Abdulaziz Tejani
Maria J. Schymura
Francis P. Boscoe
Zhaomin Xu
Carla F. Justiniano
Courtney I. Boodry
Alex A. Swanger
Katia Noyes
John R. T. Monson
Fergal J. Fleming

Background There is a paucity of literature quantifying the extent to which time to adjuvant chemotherapy for stage III colon cancer patients varies between individual surgeons, medical oncologists, and hospitals.

Keywords:

Adjuvant
Stage III Colon Cancer
Disease
Oncology
Delayed time
Medicine
Chemotherapy
Internal medicine
Surgical oncology
adjuvant chemotherapy
disease specific survival

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations